Effect of tamsulosin, a novel α1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs

Journal of Autonomic Pharmacology

Volumn 16, Issue 3, 1996, Pages 147-154

  Sudoh, K ^a   Tanaka, H ^a   Inagaki, O ^a   Asano, M ^a   Takenaka, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; CAPTOPRIL; NICARDIPINE; PRAZOSIN; TAMSULOSIN; TRICHLORMETHIAZIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; URETHRA PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NICARDIPINE; PRAZOSIN; PRESSURE; PROSTATE; QUINAZOLINES; SULFONAMIDES;

EID: 0029799594     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BRESLIN, D., FIELDS, D.W., CHOU, T.-C., MARION, D.N., KANEM, K., VAUGHAN, E.D. & FELSEN, D. (1993). Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. J. Urol., 149, 395-399.
2. BROWN, M. & WHICKHAM, J.E.A. (1969). The urethral pressure profile. Br. J. Urol., 40, 211-217.
3. BYLUND, D.B., EIKENBERG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO, R.R. & TRENDELENBURG, U. (1994). IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol. Rev., 46, 121-136.
4. BYLUND, D.B., REGAN, J.W., FABER, J.E., HIEBLE, J.P., TRIGGLE, C.R. & RUFFOLO JR, R.R. (1995). Vascular α-adrenoceptors: from the gene to the human. Can. J. Physiol. Pharmacol., 73, 533-543.
5. 1-adrenoceptor subtypes present in the human prostate. Life Sci., 54, 1595-1605.
6. 1-adrenoceptor to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur. J. Pharmacol., 288, 201-207.
7. 1-Adrenoceptor subtype selectivity of tamsulosin: studies using livers from different species. Eur. J. Pharmacol., 289, 1-7.
8. GOETZ, A.S., LUTS, M.W., RIMELE, T.J. & SAUSSY, D.L. (1994). Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes. J. Pharmacol. Exp. Ther., 271, 1226-1233.
9. 1-Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 330, 16-21.
10. HONDA, K. & NAKAGAWA, C. (1986). α-1 Adrenoceptor antagonist effects of the optimal isomers of YM-12617 in rabbit lower urinary tract and prostate. J. Pharmacol. Exp. Ther., 239, 512-516.
11. 1-adrenoceptor antagonist and its individual optical enantiomers. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 295-302.
12. 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. J. Urol., 144, 908-912.
13. 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anaesthetized dog. Urology, 44, 52-57.
14. KONDO, A. (1984). Clinical significance of urethral closure pressure profile. Shinkel Kenkyu no Shinpo, 28, 418-423 (Abs. in English).
15. KUNISAWA, Y., KAWABE, K., NIIJIMA, T., HONDA, K. & TAKENAKA, T. (1985). A pharmacological study on α adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J. Urol., 134, 396-398.
16. 1-Adrenoceptor subtypes affinities of drugs for the treatment of prostatic hypertrophy. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 385-395.
17. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 136-142.
18. MORITA, T., LATIFPOUR, J., O'HALLOREN, B., WHEELER, M.A. & WEISS, R.M. (1987). Sex differences in function and distribution of α-1 and α-2 adrenoceptors in rabbit urethra. Am. J. Physiol., 252, F1124-F1128.
19. MURAYAMA, K. (1980). Pharmacological studies in the autonomic innervation of the urethra. Jpn. J. Urol., 71, 33-50.
20. OHMURA, T., SAKAMOTO, S., HAYASHI, H., KIGOSHI, S. & MURAMATSU, I. (1993). Identification of alpha1-adrenoceptor subtypes in the dog prostate. Urol. Res., 21, 211-215.
21. ORIKAWA, K., KAKIUCHI, M., YAMAUCHI, T., HASHIMOTO, S., MIYASHITA, N., ICHIHASHI, M., SAWADA, Y., KATO, H. & ITO, Y. (1988). Effect of (±)-4′-ethyl-2-methyl-3-(1-pyrrolidinyl) propiophenone hydrochloride (HY-770) on the bladder function. Folia Pharmacol. Japon 92, 311-324 (Abs. in English).
22. 1-adrenergic receptor subtypes in human prostate. J. Urol., 150, 546-551.
23. RAZ, S. & CAINE, M. (1972). Adrenergic receptors in the female canine urethra. Infest. Urol., 9, 319-323.
24. SHIBASAKI, M., SUDOH, K., INAGAKI, O., UCHIDA, W. & HONDA, K. (1992). Effect of the optimal isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs. J. Auton. Pharmacol., 12, 263-268.
25. SHOJI, T., DAIKU, Y. & IGARASHI, T. (1980). α-Adrenoceptor blocking properties of a new antihypertensive agent, 2-[4-n-butyryl)-homopiperazine-1-yl]-4-amino-6,7-dimethoxyquinazoline (E-643). Jpn. J. Pharmacol., 30, 763-772.
26. TAKITA, T., OTANI, T., KONDO, A. & MITSUYA, H. (1983). Urodynamic study of the lower urinary tract. XII. The effect of prazosin hydrochloride in the treatment of prostatic obstruction. Jpn. J. Urol., 74, 1-14.
27. 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br. J. Pharmacol., 115, 1475-1485.
28. VARGAS, H.M. & GORMAN, A.J. (1995). Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci., 57, 2291-2308.
29. WEINER, I.M. & MUDGE, G.H. (1985). Diuretics and other agents employed in the mobilization of edema fluid. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Seventh edition. pp. 887-907. Eds A.G. Gilman, L.S. Goodman, T.W. Rall & F. Murad. Macmillan Publishing Company, New York.
30. 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur. J. Pharmacol., 121, 1-8.
31. 1-adrenoceptor antagonist binding in human prostate and aorta. Clin. Exp. Pharmacodyn. Pharmacol., 21, 405-411.
32. 1-antagonists. Life Sci., 54, 1845-1854.
33. YOSHIDA, O., TAKEUCHI, H., HIDA, S., TOMOYOSHI, T., ARAI, Y., OKADA, K., AKINO, H., ISOMATSU, Y., OKABE, T., FUKUYAMA T., KOMATSU, Y., SANADA, S., UEDA, M., TAKAHASHI, Y., NAKAMURA, K., MATSUO, M., INOUE, H., WATANABE, J., HAYASHIDA, H. & ITOKAWA, Y. (1991). Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract. Hinyokika Kiyo, 37, 421-429 (Abs. in English).